Herbal tea shows promise for sinus sufferers in tiny trial
NCT ID NCT07534280
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small study tested a herbal tea made from berry and mango leaves in 10 adults with acute sinusitis. Participants drank the tea three times a day alongside their usual care for one month. Researchers measured changes in quality of life using a standard symptom questionnaire. The goal was to see if the tea could safely help reduce symptoms and improve daily well-being.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- berry leaves and mango leaves herbal tea mixture
- What this could lead to
- If it works, this could offer a natural, low-cost option to help people feel better during a sinus infection.
- What could go wrong
- This was a very small, early study with only 10 people, so results may not apply widely. The herbal tea was added on top of standard treatments, making it hard to know if the tea alone helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Nov 2025
- Finished
-
Mar 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The subject must have symptoms of acute bacterial rhinosinusitis. * The subject should be able to be self-assessed as moderate, severe, or very severe. * The subject must have access to a phone. * The subject must accept sharing and sign consent. * The subject should follow instructions carefully and not miss times of assessment Exclusion Criteria: * The subject has an allergy to: Flavonoids, phenolic acids, anthocyanins, carotenoids. * The subject has complications of sinusitis (facial edema, cellulitis, or orbital, meningeal or cerebral signs). * The subject is pregnancy. * The subject has a comorbidity that may impair their immune response (such as immunodeficiency disease, uncontrolled cancer, or chemotherapy or radiation treatment). * The subject has cystic fibrosis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Rhino sinusitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Deraya university
Minya, 05673, Egypt
-
Soad A. Mohamad
Minya, Minya Governorate, 05673, Egypt